Business Context and Reporting Period
Company: NeuroOne Medical Technologies Corp (NMTC)
Filing Type: Form 8-K (Current Report)
Date of Report: August 27, 2026
Reporting Period: Single event date (August 27, 2026)
The filing reports a specific corporate event under Item 8.01 (Other Events) regarding the advancement of the Company's StereoCED® platform.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a clinical development milestone and does not contain financial statements or quantitative financial data.
Material Changes
There are no financial material changes reported in this filing. The material event is operational:
- On August 27, 2026, the Company announced the completion of three procedures in large animals using its StereoCED® platform.
- A press release detailing this event is filed as Exhibit 99.1.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) regarding the large animal procedures but does not include specific management commentary, forward-looking guidance, or risk factors within the body of this 8-K text.
Unusual Items: None reported beyond the standard clinical milestone announcement.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific details on the large animal procedure outcomes and safety data.
- Verify the timeline for subsequent clinical trials or regulatory filings following these large animal studies.
- Check recent 10-K or 10-Q filings for the most current financial position, as this 8-K contains no financial data.